Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
The Schmooze

"Rhoda" Actress Puts On A Brave Face

Valerie Harper, known for her role as Rhoda Morgenstern on “The Mary Tyler Moore Show” —remember those headscarves? — revealed yesterday that she had been diagnosed with terminal brain cancer. On January 15, her doctors told her that she had as little as three months left to live.

In a tear-jerker interview with People Magazine, Harper explained that she had been diagnosed after her face went numb during rehearsal. “It hit me like a sledge hammer,” she told People Magazine. “I was terrified.”

Harper also revealed that though she will undergo chemotherapy, she has come to terms with her fate. ““I have a fighting chance until I’m gone, [but] I’m well passed my expiration date already,”she said.

The Emmy-winning actress, who also starred in her own spinoff, “Rhoda,” had previously battled lung cancer in 2009.

The Emmy-winning actress, who also starred in her own spinoff, “Rhoda,” had previously battled lung cancer in 2009.

Harper’s former colleagues and friends were shocked by the revelation, People reported.

I’m absolutely devastated by this news,” said Mary Tyler Moore, 76. “Valerie has given so much joy, laughter and love to the world — I join her fans and send much love and positive thoughts to her and her family during this difficult time.”

Hollywood matriarch extraordinaire Betty White, who played Sue Ann Perkins in the 1970s classic, told the New York Post: “Here I go wheezing on at 91 years old, and this beautiful, beautiful lady is facing something far too soon. We all love her so much, and we are going to make the most of every second we can.”

But some, like Harper herself, are fighters to the end.“I have every confidence in the world that she will shock the hell out of us and survive — to keep functioning as the great talent and human that she is,” Ed Asner, who played producer Lou Grant, told the New York Post.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you move on, I wanted to ask you to support the Forward’s award-winning journalism during our High Holiday Monthly Donor Drive.

If you’ve turned to the Forward in the past 12 months to better understand the world around you, we hope you will support us with a gift now. Your support has a direct impact, giving us the resources we need to report from Israel and around the U.S., across college campuses, and wherever there is news of importance to American Jews.

Make a monthly or one-time gift and support Jewish journalism throughout 5785. The first six months of your monthly gift will be matched for twice the investment in independent Jewish journalism. 

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version